Tag: GSK

Maria José Schmidt-Kessen (Copenhagen Business School)1   Introduction While we are still awaiting the judgments in the pending appeals on pay-for-delay settlements in Lundbeck2 and Servier,3 the...

According to Reuters, GlaxoSmithKline has offered concessions to address EU antitrust concerns over its planned joint venture with Pfizer’s consumer health business, the European Commission...

GlaxoSmithKline and Pfizer announced they would combine their consumer health businesses in a joint venture with sales of £9.8 billion (US$12.7 billion), majority owned...

In this issue: Defining the Market for Organic Foods Thomas Lambert, Jun 14, 2007 Ignoring the Lessons of Von's Grocery: Some Thoughts on the FTC's Opposition to...

This article is part of a Chronicle. See more from this Chronicle Jeremy de Douhet, Axel Schulz, Jun 14, 2007 This article was originally published in...